You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康哲药业(00867.HK)皮肤线主要产品喜辽妥进入医保目录
格隆汇 08-20 21:41

格隆汇8月20日丨康哲药业(00867.HK)宣布,根据国家医疗保障局及国家人力资源和社会保障部于2019年8月20日发布的通知,集团产品喜辽妥(多磺酸粘多糖乳膏)被纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2019版)》乙类范围管理,并将自2020年1月1日起正式实施。

喜辽妥为集团自有品种及皮肤线主要产品,且为中国大陆唯一的多磺酸粘多糖制剂产品。于2015年3月25日集团从大昌华嘉国际处购得喜辽妥在中国大陆的相关资产。截至2019年6月30日止六个月,集团皮肤线实现收入人民币8600万元,较去年同期增长16.5%,占集团还原"两票制"营业额的2.5%。

公司预期喜辽妥进入医保目录乙类范围後将有利于喜辽妥市场份额的扩大、市场布局的拓展,对集团今后的销量增长和长远发展产生积极作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account